5th October 2020
- 0 comments
Immune Regulation Limited, a US and UK based clinical stage biotechnology company, has closed a Series B funding round led by Boston based Morningside Ventures, alongside existing shareholders including London based 24Haymarket.
...Register / Login now to read full story
In order to read the full story we need you to be registered with us, please click the links below to login or register.
Back to Homepage